SCHEMBL30983958

SCHEMBL30983958

CC(C)(C)OC(=O)N1CCN(CCOc2ccc(-c3nc4c(OC5(C)CC5)ncnc4n3Cc3ccccc3)c(Cl)c2Cl)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.40
▸ CNR2 P34972 2/20 0.40
▸ PIK3CD O00329 6/20 0.38
▸ OPRD1 P41143 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ EPHX2 P34913 2/20 0.36
▸ GPR4 P46093 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ACKR3 P25106 1/20 0.35
▸ SQOR Q9Y6N5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983956 1.00 CNR1 (0.40) CNR1CNR2PIK3CDOPRD1OPRK1
SCHEMBL30983780 0.95 CNR1 (0.41) CNR1CNR2PIK3CDOPRD1OPRK1
SCHEMBL30983859 0.94 CNR1 (0.39) CNR1CNR2PIK3CDOPRD1OPRK1
SCHEMBL30983948 0.90 CNR1 (0.41) CNR1CNR2PIK3CDOPRD1OPRK1
SCHEMBL30983989 0.89 PIK3CD (0.42) CNR1CNR2PIK3CDOPRD1OPRK1
SCHEMBL30983802 0.89 CNR1 (0.43) CNR1CNR2PIK3CDTP53THRB
SCHEMBL30983837 0.88 CNR1 (0.40) CNR1CNR2PIK3CDRXFP1BRD4
SCHEMBL30983452 0.86 HTR1D (0.40) CNR1CNR2PIK3CDMCL1THRB
SCHEMBL30983893 0.85 CNR1 (0.42) CNR1CNR2PIK3CDEPHX2GPR4
SCHEMBL30983408 0.85 DRD2 (0.36) PIK3CDMCL1KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback